Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,579 | 32,172 | 37,265 | 43,145 | 50,392 |
| TOTAL | $27,603 | $35,380 | $39,289 | $45,596 | $53,493 |
| Non-Current Assets | |||||
| PPE Net | 225 | 229 | 244 | 275 | 306 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 547 | 358 | 381 | 403 | 425 |
| TOTAL | $11,920 | $11,735 | $11,773 | $11,826 | $11,879 |
| Total Assets | $39,523 | $47,115 | $51,062 | $57,422 | $65,372 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,888 | 6,554 | 5,032 | 4,819 | 6,362 |
| TOTAL | $3,888 | $6,554 | $5,032 | $4,819 | $6,362 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 497 | 293 | 346 | 412 | 593 |
| TOTAL | $497 | $293 | $346 | $412 | $593 |
| Total Liabilities | $4,385 | $6,847 | $5,378 | $5,231 | $6,955 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80 | 80 | 79 | 76 | 76 |
| Common Shares | 30 | 30 | 30 | 29 | 29 |
| Retained earnings | -121,335 | -115,726 | -109,750 | -101,835 | -95,065 |
| Other shareholders' equity | -3 | 7 | 8 | 12 | 3 |
| TOTAL | $35,138 | $40,268 | $45,684 | $52,191 | $58,417 |
| Total Liabilities And Equity | $39,523 | $47,115 | $51,062 | $57,422 | $65,372 |